प्राथमिक स्रोत रिकॉर्ड

pembrolizumab · NCT06295731 रजिस्ट्री अपडेट

स्थिति: ACTIVE_NOT_RECRUITING → RECRUITING; प्राथमिक_समापन: 2029-05 → 2029-12; समापन: 2029-05 → 2031-05; नामांकन: 410 → 450; प्राथमिक_परिणाम: ['Phase 2: Objective Response Rate (ORR)', 'Phase 3: Progression-Free Survival (PFS)', 'Phase 3: Overall Survival (OS)'] → ['Phase 2: Objective Response Rate by investigator (ORRinv)', 'Phase 3: Progression-Free Survival by Investigator (PFSinv)', 'Phase 3: Overall Survival (OS)']; देश: {'total_sites': 87, 'us_sites': 25} → {'total_sites': 89, 'us_sites': 26}